Sign up to save your podcasts
Or
Share AAMI ST:91 – A Review of the New Standards and Discussion on Enhanced Compliance
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AAMI ST:91 – A Review of the New Standards and Discussion on Enhanced Compliance
Preventing HAIs (healthcare-acquired infections) is critical in sterilization and quality control processing. Maintaining AAMI ST-91 guidelines ensures adherence to the latest sterilization and quality control methods for endoscopes. And with over 51.4 million inpatient surgeries performed in the U.S. each year, keeping up-to-date guidelines for AAMI ST-91 is paramount.
How do the updated AAMI ST-91 guidelines improve endoscope reprocessing and enhance compliance?
In this ConCensis episode brought to you by Censis Technologies, host Gabrielle Bejarano discusses the updates to the AAMI ST-91 guidelines, focusing on endoscope reprocessing. The discussion addresses the challenges and importance of proper cleaning, the impact of ST-91 requirements, and the role of electronic tracking systems in enhancing compliance and patient safety. Kelly Swails, Clinical Business Manager at Censis Technologies, and Mary Ann Drosnock, Director of Clinical Affairs at Healthmark Industries joined Bejarano to delve into the challenges associated with endoscope reprocessing, the significance of the AAMI ST-91 guidelines, and the implementation of electronic tracking systems to streamline processes and improve patient safety.
Bejarano’s discussion with Swails and Drosnock includes:
- The challenge of endoscope cleaning and the significance of the ST-91 guidelines:
- AAMI (Association for the Advancement in Medical Instrumentation) and its role in enhancing compliance and patient safety
- Adoption and impact of updated guidelines
About Kelly
Kelly Swails is the Clinical Business Manager at Censis Technologies with experience in endoscope reprocessing and implementing electronic tracking systems. She received her M.A. in organization leadership from the University of Northwestern, St. Paul.
About Mary Ann
Dr. Mary Ann Drosnock is the Director of Clinical Affairs at Healthmark Industries, where she provides expertise in medical device processing and infection prevention and leads an experienced team of Clinical Educators. For nine years, she was co-chair of AAMI WG 84, which writes ST91, the national standard on flexible endoscope reprocessing, and TIR99 on the processing of ultrasound probes and dilators. Before Healthmark, Mary Ann managed the Infection Control Program for Olympus America, worked and managed labs as a pharmaceutical microbiologist, and taught Microbiology courses at the college level. MaryAnn has a B.S. in Biology, an M.S. in Quality and Regulatory Affairs, and a DrHSc in Healthcare Administration and Management.
View all episodes
By A Sterile Processing Podcast from Censis
4.8
44 ratings
Preventing HAIs (healthcare-acquired infections) is critical in sterilization and quality control processing. Maintaining AAMI ST-91 guidelines ensures adherence to the latest sterilization and quality control methods for endoscopes. And with over 51.4 million inpatient surgeries performed in the U.S. each year, keeping up-to-date guidelines for AAMI ST-91 is paramount.
How do the updated AAMI ST-91 guidelines improve endoscope reprocessing and enhance compliance?
In this ConCensis episode brought to you by Censis Technologies, host Gabrielle Bejarano discusses the updates to the AAMI ST-91 guidelines, focusing on endoscope reprocessing. The discussion addresses the challenges and importance of proper cleaning, the impact of ST-91 requirements, and the role of electronic tracking systems in enhancing compliance and patient safety. Kelly Swails, Clinical Business Manager at Censis Technologies, and Mary Ann Drosnock, Director of Clinical Affairs at Healthmark Industries joined Bejarano to delve into the challenges associated with endoscope reprocessing, the significance of the AAMI ST-91 guidelines, and the implementation of electronic tracking systems to streamline processes and improve patient safety.
Bejarano’s discussion with Swails and Drosnock includes:
- The challenge of endoscope cleaning and the significance of the ST-91 guidelines:
- AAMI (Association for the Advancement in Medical Instrumentation) and its role in enhancing compliance and patient safety
- Adoption and impact of updated guidelines
About Kelly
Kelly Swails is the Clinical Business Manager at Censis Technologies with experience in endoscope reprocessing and implementing electronic tracking systems. She received her M.A. in organization leadership from the University of Northwestern, St. Paul.
About Mary Ann
Dr. Mary Ann Drosnock is the Director of Clinical Affairs at Healthmark Industries, where she provides expertise in medical device processing and infection prevention and leads an experienced team of Clinical Educators. For nine years, she was co-chair of AAMI WG 84, which writes ST91, the national standard on flexible endoscope reprocessing, and TIR99 on the processing of ultrasound probes and dilators. Before Healthmark, Mary Ann managed the Infection Control Program for Olympus America, worked and managed labs as a pharmaceutical microbiologist, and taught Microbiology courses at the college level. MaryAnn has a B.S. in Biology, an M.S. in Quality and Regulatory Affairs, and a DrHSc in Healthcare Administration and Management.